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deoxyadenylate and deoxyguanylate residues, and the second strand contains
alternating deoxycytidine and thymidine residues.
* This is paper XXXIX in the series "Studies on Polynucleotides." Paper XXXVIII is by S.
Nishimura, T. M. Jacob, and H. G. Khorana [these PROCEEDINGS, 52, 1494 (1964)]. This
work has been supported by grants from the National Science Foundation and the National
Cancer Institute of the National Institutes of Health.
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IN VITRO SYNTHESIS OF PARTICULATE GLYCOGEN*
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Communicated October 30, 1964
High-molecular-weight glycogen was first extracted from liver by Lazarow,I who
called it particulate glycogen. Since then, it has been studied by several workers,2 3
but it is not known whether it is composed of a-1,4 and a-1,6 linked glucose residues
only or if, in addition, it has other types of linkages or materials.
The molecular weight of particulate glycogen has been estimated2 to be 50-200(X
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106 that of glycogen extracted with cold trichloroacetic acid4 5-70 X 106, and val-
ues of 1-3 X 106 have been assigned to alkali-extracted glycogen.4
When observed with the electron microscope,5 6 liver particulate glycogen appears
as clusters or rosettes of 60-200 mg diameter composed of subparticles of 20-40 myu
diameter. The rosettes and the subparticles have been referred to as a and A
particles, respectively, by Drochmans.5
The mechanism of glycogen synthesis is fairly well known7-9 but, to our knowledge
no work has been done on the in vitro synthesis of particulate glycogen. It was
reasoned that starting with a high donor/acceptor ratio it should be possible to
attain very high molecular weights. In fact, by incubating glucose 1-phosphate,
glycogen, and purified enzymes in the right proportions, it has been possible to
prepare glycogen which appears to be the same as that obtained by cold water
extraction of liver. By a similar procedure, Illingworth, Brown, and Cori10 had
prepared glycogen of a molecular weight: 25 X 106.
It is generally believed that the natural donor for glycogen synthesis is uridine
diphosphate D-glucose,78 11 but it was found more convenient to use glucose
1-phosphate and phosphorylase because they can be obtained in quantity and in
pure form. Since glycogen synthetase and phosphorylase have the same acceptor
specificity,8' 12 it seemed likely that the polysaccharide formed would be the same.
Materials and Methods.-Crystalline phosphorylase b from rabbit muscle and
purified branching enzyme from rat liver were prepared as described by Fischer,
Krebs, and Kent"3 and Krisman,'4 respectively. Glycogen and branching activity
were measured according to Krisman.14, 15
Particulate glycogen was extracted from the livers of sucrose-fed rats. Homogeni-
zation was carried out in 3 vol of 0.1 M glycine buffer, pH 10.4, followed by centrif-
ugation as described previously.16 The glycogen pellet was resuspended in the
glycine buffer, and proteins were removed with chloroform and isoamyl alcohol as
described by Sevag, Lackmann, and Smolens.17 Alkali-extracted glycogen was
prepared as described by Somogyi. 18
Electron microscopy was carried out after negative staining with phosphotung-
state. The procedure was as follows: grids, covered with Formvar and coated with
carbon, were immersed in a detergent solution (1% Triton X-100), washed with
distilled water, and dried. A thin film of glycogen solution (about 2%) was
extended over the grids with a wire loop. Excess liquid was sucked off with filter
paper, and then a film of 2-4 per cent phosphotungstate was applied in a similar
manner. The latter was prepared by neutralizing phosphotungstic acid with
tris(hydroxymethyl)aminomethane. Observations were carried out in the electron
microscope (Siemens-Elmiskop I) with a double condenser, and photographs were
taken at 30,000 or 40,000 direct magnifications.
Results.-In vitro synthesis: The sedimentation of different glycogen samples was
studied in preliminary experiments. After centrifugation at 11,300 X g for 10 min,
it was found that the sedimentation of particulate glycogen was 78 per cent while
that of alkali-extracted glycogen was only 7 per cent.
The results of incubating glucose 1-phosphate, phosphorylase, and branching
enzyme are shown in Table 1. It may be observed that in sample 1, 76 per cent of
the glycogen was sedimentable. In the other samples, the proportion of sediment-
able glycogen formed depended on the amount of acceptor present. Thus, sample 5
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in which glycogen was present only as an impurity of some of the reagents gave the
highest value (93%). In contrast, sample 7 in which more glycogen was added
initially gave a value of only 10 per cent. In sample 8, in which a larger amount of
alkali-extracted glycogen was added but glucose 1-phosphate was omitted, no
sedimentable glycogen was formed. This shows that the proteins (phosphorylase
and branching enzyme) do not produce aggregation by themselves.
TABLE 1
In vitro FORMATION OF PARTICULATE GLYCOGEN
KOH- Final Per cent X maximum
Sample glycogen glycogen sediment- with iodinet
no. added (mg) (mg) able* (m.U)
1 Complete system 0.01 3.6 76 460
2 No glucose 1-phosphate 0.01 <0.2
3 No phosphorylase b 0.01 <0.2
4 No branching enzyme 0.01 Blue color
5 No glycogen 3.15 93 460
6 No additional adenosine 5'- 0.01 0.92 55
phosphate
7 Complete plus additional 0.33 3.5 10 400-460
glycogen
8 No glucose 1-phosphate, ex- 3.3 3.15 0
cess glycogen
The complete system contained: 35 ,gmoles of glucose 1-phosphate, 0.13 ,umoles of adenosine 5'-phosphote,
17 jg of phosphorylase b, 0.1 ml of liver branching enzyme. Total volume 0.22 ml. After 30 min at 370,
0.2 ml of 0.1 M glycine buffer of pH 10 was added. The branching enzyme was estimated according to Kris-
man.14 Ten pl of the preparation gave a A absorbancy at 520 my of 0.47 per 30 min.
* The samples were analyzed for glycogen before and after centrifugation at 11,300 X g for 10 min. The
difference was taken as sedimentable glycogen.
t Under the conditions described by Krisman.15
The absorption maximum in the presence of iodine was at 460 m/u both for the
glycogen synthesized in vitro and for the particulate glycogen isolated from liver.
In some experiments in which phosphorylase was relatively more active than
the branching enzyme, the polysaccharide gave at first a purple color with iodine,
similar to that given by amylopectin. On further incubation or on addition of more
branching enzyme the color became brown like that of glycogen.
Electron microscopy: When observed with the electron microscope, the partic-
ulate glycogen isolated from rat liver (Fig. 1A) appeared as particles of various
sizes. The diameter of most of them was 80-100 mju, and the extreme values were
20 and 180 mAu. The subparticles had a diameter of 10-24 mAu. The results were
therefore similar to those described by other workers.
The glycogen prepared in vitro (Fig. 1B) with the complete system as described in
Table 1, was composed of particles of slightly more uniform size, most of them of
90-100 mju diameter with extreme values of 40 and 160 m/u. The subparticles had a
diameter of 14-25 mAu. The general appearance was identical to that of particulate
glycogen isolated from liver. Figure 1C shows, for comparison, the appearance of
alkali-extracted glycogen.
Effect of dilution: As shown in Table 2, dilution of the glycogen-forming system
did not decrease the proportion of sedimentable glycogen formed.
Overgrown molecules: In order to ascertain whether there is an upper limit for the
size of the particles, glycogen was prepared as described for sample 5 in Table 1.
After incubation, glycogen was separated by centrifugation and treated again with
enzymes and substrate. The procedure was repeated three times. This glycogen
could be sedimented with a very low centrifugal force: for instance, 80 per cent of it
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TABLE 2
EFFECT OF DILUTION
Final volume Incubation time Glycogen formed Per cent
Sample no. (ml) (min) (mg) sedimentable
1 0.13 45 2.1 88
2 0.27 75 2.0 90
3 0.41 120 1.7 88
Complete system as in Table 1 but with different total volumes.
was sedimented at 700 X g for 20 min, while only 6 per cent of the liver particulate
glycogen sedimented under the same conditions. Observation with the electron
microscope (Fig. iD) revealed enormous particles of up to 380 m1t diameter. The
subparticles had a diameter of 15-25 mIn.
Discussion. -The glycogen formed in vitro from glucose 1-phosphate appears to be
identical to particulate glycogen isolated from liver, as judged by sedimentation in
the centrifuge and its appearance when observed with the electron microscope.
This fact permits some deductions on the nature of the link which joins the subpar-
ticles. Since purified enzymes were used for the in vitro synthesis, it seems very
unlikely that any other type of bond in addition to the a-1,4 and a-1,6 glucosidic
linkages could have been formed. Low-molecular-weight glycogen did not become
particulate in the absence of glucose 1-phosphate, so that none of the proteins used
in the test produced aggregation per se.
A possibility which has to be considered is that as the subparticles grow, they may
become entangled so that larger aggregates are formed. If this were the case, it
would be expected that less particulate glycogen would be formed on dilution.
In fact, no change was observed on increasing the volume 3-fold (Table 2).
It has been shown that liver particulate glycogen can be obtained practically
free from protein and that treatment with urea, detergents, trypsin, or chymotryp-
sin2 does not cause disaggregation. According to this evidence and that presented
in this paper, it appears unlikely that particulate glycogen contains any other type
of bond besides the glucosidic. However, it has been pointed out that this type of
glycogen is degraded by acid or alkali at a rate which seems to be greater than that of
alkali-extracted glycogen. This fact might be explained as follows. Assuming that
glycogen has a regular structure in which the branches divide into two at regular
intervals, Pollard'9 calculated that there is a maximum limit in molecular dimensions
when the diameter reaches 26-40 mp. When this sizeis attained, further growth
becomes impossible because no more glucose residues can be packed in a sphere
of that diameter. The maximum diameter calculated by Pollard corresponds to
that of the subparticles observed with the electron microscope. Growth beyond
that size could occur, but irregularly. A branch could grow out of the subparticle
and thus start another particle; repetition of this process would give rise to par-
ticulate glycogen. The bonds between subparticles would be a-1,4 glucosidic but
they would be expected to break easily under the strain produced by the thermal
agitation of the subparticles. Thiswould explain the lability of particulate glycogen.
Summary.-Incubation of glucose 1-phosphate with crystalline phosphorylase
and purified branching enzyme leads to the formation of particles which are undis-
tinguishable from particulate glycogen as judged by their rate of sedimentation or by
their appearance when observed with the electron microscope. The structure of
particulate glycogen is discussed in view of the evidence presented.
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THE SPECIFIC INHIBITION OF THE ENZYMATIC
AMINOACYLATION OF VALYL- AND TYROSYL-sRNA BY
PP1RIODATE-OXIDIZED sRNA
BY JESUS TORRES-GALLARDO* AND MILTON KERN
NATIONAL INSTITUTE OF ARTHRITIS AND METABOLIC DISEASES,
NATIONAL INSTITUTES OF HEALTH, BETHESDA, MARYLAND
Communicated by C. B. Anfinsen, November 2, 1964
Chapeville et al.1 observed that alanine, linked to cysteine specific sRNA, was
introduced into the position normally occupied by cysteine during polypeptide
synthesis. Their experiments provided direct evidence that messenger RNA
recognizes only the sRNA moiety of aminoacyl-RNA. In this sense, the specificity
of the interaction of sRNA with the appropriate aminoacyl-RNA synthetase plays
a crucial role in determining the amino acid sequence of protein. The findings that
the aminoacyl-RNA synthetases could be separated2 and amino acid specific sRNA's
could be isolated3 are consistent with this view.
